Learning Objectives: -Provide an overview of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) -Explain the progression from MDS to AML, including the factors that influence the transformation and the clinical implications -Discuss the diagnostic criteria for distinguishing MDS from AML -Describe the treatment options and management strategies for both MDS and AML, including emerging therapies -Review resources and education to support patients, caregivers, and healthcare professionals
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://www.llsce.org/treating-myelodysplastic-syndromes-transformation-to-acute-myeloid-leukemiaselection-page/
- Start Date: 2024-10-28 05:00:00
- End Date: 2024-10-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest